Samsung: $27M by year-end Lantheus Holdings (Pro
Post# of 148179
(Total Views: 862)
Posted On: 12/13/2020 9:43:38 PM
Samsung: $27M by year-end
Lantheus Holdings (Progenics): 5% of Net Sales
AbbVie: 3.5 - 4.5% of Net Sales (subject to further clarification by Cytodyn)
American Regent: Not publicly available
Chiral Pharma: Not publicly available
IncellDX: Subject to outcome of patent applications
Lantheus Holdings (Progenics): 5% of Net Sales
AbbVie: 3.5 - 4.5% of Net Sales (subject to further clarification by Cytodyn)
American Regent: Not publicly available
Chiral Pharma: Not publicly available
IncellDX: Subject to outcome of patent applications
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼